Study: THC/CBD Spray Provides Pain Relief to Multiple Sclerosis Patients

Sativex, a medical spray made from cannabis using equal parts THC and CBD, is effective in providing pain relief to those with multiple sclerosis, according to newly released research.

“Delta-9-tetrahydrocannabinol (THC)/cannabidiol (CBD) (nabiximols or Sativex®) is an oromucosal spray formulation containing THC and CBD at an approximately 1:1 fixed ratio”, states the abstract of the study, which was published by the open access journal Medicines. “Its administration for the treatment of pain in patients with multiple sclerosis (MS) has been established. ”

Noting that “MS patients generally complain of different kinds of pain, including spasticity-related and neuropathic pain”, researchers “compared and evaluated pain modulation and thermal/pain threshold of MS patients before and after THC/CBD administration.” 19 MS patients underwent “clinical examination, numerical rating scale (NRS), quantitative sensory testing (QST), and laser-evoked potentials (LEPs) before and after 1 month of therapy.” Psychophysiological and neurophysiological data were compared to sex- and age-matched controls.

Read moreStudy: THC/CBD Spray Provides Pain Relief to Multiple Sclerosis Patients

Cannabinoids May Treat Oxidative Stress-Related Neurodegenerative Disorders, Says New Study

Cannabinoids have therapeutic potential in oxidative stress-related acute or chronic neurodegenerative disorders from stroke, multiple sclerosis and traumatic brain injury to Alzheimer`s and Parkinson`s diseases, according to a new study.

The study, conducted by researchers at the National Institute of Health (NIH) and Rutgers New Jersey Medical School, is being published in the journal Antioxidants & Redox Signaling, and has been e-published ahead of print by NIH’s PubMed.gov.

According to the study’s abstract:

Read moreCannabinoids May Treat Oxidative Stress-Related Neurodegenerative Disorders, Says New Study

Hawaii Bill Adding Five New Medical Cannabis Conditions Passes House Committee

The Hawaii House Health Committee has passed a measure that wold expand the state’s medical cannabis program. They also unanimously passed a bill to change state law to refer to “medical marijuana” as “medical cannabis”.

Senate Bill 174, which has already passed the Senate with a unanimous 25 to 0 vote, passed the House Health Committee yesterday; the vote was 4 to 2. The proposal would add lupus, epilepsy, multiple sclerosis, arthritis and autism as conditions that qualify someone to become a legal medical cannabis patient.

Currently medical cannabis use in Hawaii is limited to those with cancer, glaucoma, HIV/AIDS or a “chronic or debilitating disease or medical condition or its treatment that produces” cachexia, severe pain or nausea, seizures, sever muscle spasms or post traumatic stress disorder.

Read moreHawaii Bill Adding Five New Medical Cannabis Conditions Passes House Committee

Hawaii Senate Votes Unanimously to Allow Medical Cannabis for Lupus, Epilepsy, Multiple Sclerosis, Arthritis and Autism

A Hawaii measure that would expand the list of qualifying medical cannabis conditions has been passed by the state’s full Senate.

Senate Bill 174 was passed today with a unanimous 25 to 0 vote. It now goes to the House of Representatives, where its passage will send it to Governor David Ige for consideration.

If passed into law, the proposal would allow those with lupus, epilepsy, multiple sclerosis, arthritis and autism to become registered medical cannabis patients, allowing them to possess, purchase (from a licensed dispensary) and use cannabis and cannabis products for medical use.

Read moreHawaii Senate Votes Unanimously to Allow Medical Cannabis for Lupus, Epilepsy, Multiple Sclerosis, Arthritis and Autism

Florida Officials Begin Issuing Medical Marijuana Cards to Patients

Florida’s Office of Compassionate Use has officially started issuing medical marijuana cards to patients and caregivers.

florida medical marijuanaAccording to Mara Gambinieri, spokesperson for the state’s Department of Health, their Office of Compassionate Use began processing patient applications once the state’s new medical marijuana rules took effect on February 19th.

Under the state’s law, those with a qualifying condition who receive a recommendation from a physician to use medical marijuana can apply with the department to do so. Qualifying conditions include HIV/AIDS, cancer, epilepsy, glaucoma, post traumatic stress disorder (PTSD), multiple sclerosis, Parkinson’s disease, chronic muscle spasms, amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease) and Crohn’s disease.

Read moreFlorida Officials Begin Issuing Medical Marijuana Cards to Patients

THC May Treat Spasticity and Pain Associated with Multiple Sclerosis, According to New Research

The oral administration of Δ9-tetrahydrocannabinol (THC) may treat both spasticity and pain associated with multiple sclerosis.

Multiple SclerosisThis is according to a study being published by the journal Clinical Therapeutics, and e-published ahead of print by the U.S. National Institute of Health.

According to the Mayo Clinic, multiple sclerosis (MS) is a “disease in which the immune system eats away at the protective covering of nerves.” The ailment affects around 200,000 people annually and has no cure. Multiple sclerosis causes many different symptoms, including vision loss, pain, fatigue, and impaired coordination.

The aim of the present study was to “evaluate the efficacy of an oral formulation of Δ9-tetrahydrocannabinol (ECP002A) in patients with progressive multiple sclerosis (MS).”

Read moreTHC May Treat Spasticity and Pain Associated with Multiple Sclerosis, According to New Research

Tennessee House Committee Passes Medical Cannabis Legalization Bill

A proposalmedicanna to legalize the use of cannabis-based medicines for those with a recommendation from a physician has been approved with a unanimous vote by Tennessee’s House Health Subcommittee. The full committee is expected to begin discussing the bill next week.

If approved into law, the proposal – sponsored by Representative Ryan Williams (R-Cookeville) – would allow those with stage II, III or IV terminal cancer, Parkinson’s disease, multiple sclerosis, Huntington’s disease and certain forms of epilepsy to possess and use cannabis pills or patches, if they receive a recommendation from a physician and register with the Tennessee Department of Health. Unfortunately dried cannabis flower will remain illegal even for medical use.

Read moreTennessee House Committee Passes Medical Cannabis Legalization Bill

Florida Senate Committee Unanimously Passes Medical Cannabis Bill

Florida’s floridaSenate Health Policy Committee voted 8 to 0 Tuesday to approve Senate Bill 7066, a proposal to greatly expand upon a medical cannabis bill approved by state lawmakers – and signed by Governor Rick Scott – in 2014. The bill has already been approved by the Senate Regulated Industries Committee.

In July, Governor Rick Scott signed into law a proposal that legalized the possession, use and state-licensed distribution of low-THC cannabis extracts for the treatment of cancer, epilepsy and amyotrophic lateral sclerosis (ALS). Senate Bill 7066 would add multiple sclerosis, Crohn’s disease, HIV/AIDS, Parkinson’s disease, paraplegia, quadriplegia and terminal illness to the list of conditions that qualify an individual to purchase and use cannabis medicines.

Read moreFlorida Senate Committee Unanimously Passes Medical Cannabis Bill

Study: Cannabinoids May Treat Symptoms of MS, ALS, Huntington’s, Alzheimer’s and Parkinson’s Diseases

A study published recently in the International Journal of High Risk Behavior and Addiction, and published online by thecannabinoids U.S. National Institute of Health, has found that cannabinoids may treat the symptoms of a large variety of neurodegernative diseases including multiple sclerosis, amyotrophic lateral sclerosis, Huntington’s disease, Parkinson’s disease and Alzheimer’s disease.

“The aim of this review is to highlight the role of endocannabinoid system in neurodegenerative diseases”, claims the abstract of the study, which researchers call “a critical analysis of the most recent data currently present in scientific literature on the subject; a qualitative synthesis of only the most significant articles has been performed.”

Read moreStudy: Cannabinoids May Treat Symptoms of MS, ALS, Huntington’s, Alzheimer’s and Parkinson’s Diseases

Long-Term Use of Cannabis Spray Effective in Treating Multiple Sclerosis Spasticity, Says Study

A study published last week by the journal European Neurology has found that the long-term use of Sativex, a spray made from the cannabis plant (one part THC, one part CBD), is effectivesativex1 in treating multiple sclerosis spasticity.

According to researchers, the study’s objective was to “provide long-term data on clinical outcomes, tolerability, quality of life and treatment satisfaction for MSS [multiple sclerosis spasticity] patients receiving nabiximols [Sativex] in routine care.”

Read moreLong-Term Use of Cannabis Spray Effective in Treating Multiple Sclerosis Spasticity, Says Study